SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 425 - Prospectuses and communications, business combinations:
SEC Accession No. 0001140361-19-004364
Filing Date
2019-03-04
Accepted
2019-03-04 17:23:32
Documents
5

Document Format Files

Seq Description Document Type Size
1 425 s002715x1_425.htm 425 20283
2 s002715x1_image01.jpg GRAPHIC 99422
3 s002715x1_image02.jpg GRAPHIC 3264
4 s002715x1_image03.jpg GRAPHIC 3208
5 s002715x1_image04.jpg GRAPHIC 1427
  Complete submission text file 0001140361-19-004364.txt   170167
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filed by) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425
SIC: 2834 Pharmaceutical Preparations

Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Subject) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 425 | Act: 34 | File No.: 001-37568 | Film No.: 19655178
SIC: 2834 Pharmaceutical Preparations